These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In Vivo Administration of Splice Switching PNAs Using the mdx Mouse as a Model System. Brolin C; Lim EWK; Nielsen PE Methods Mol Biol; 2020; 2105():241-250. PubMed ID: 32088875 [TBL] [Abstract][Full Text] [Related]
5. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice. Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790 [TBL] [Abstract][Full Text] [Related]
6. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y; Yagi M; Wada H; Matsuo M Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [TBL] [Abstract][Full Text] [Related]
8. Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Yin H; Betts C; Saleh AF; Ivanova GD; Lee H; Seow Y; Kim D; Gait MJ; Wood MJ Mol Ther; 2010 Apr; 18(4):819-27. PubMed ID: 20068555 [TBL] [Abstract][Full Text] [Related]
9. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. Hanson B; Wood MJA; Roberts TC RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516 [TBL] [Abstract][Full Text] [Related]
10. Approaches for Systemic Delivery of Dystrophin Antisense Peptide Nucleic Acid in the mdx Mouse Model. Brolin C; Lim EWK; Grizot S; Olsen CH; Yavari N; Krag TO; Nielsen PE Nucleic Acid Ther; 2021 Jun; 31(3):208-219. PubMed ID: 32678992 [TBL] [Abstract][Full Text] [Related]
11. Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice. Hiller M; Spitali P; Datson N; Aartsma-Rus A Methods Mol Biol; 2018; 1828():249-262. PubMed ID: 30171546 [TBL] [Abstract][Full Text] [Related]
12. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. Moulton HM; Moulton JD Biochim Biophys Acta; 2010 Dec; 1798(12):2296-303. PubMed ID: 20170628 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. Wang Q; Yin H; Camelliti P; Betts C; Moulton H; Lee H; Saleh AF; Gait MJ; Wood MJ J Gene Med; 2010 Apr; 12(4):354-64. PubMed ID: 20235089 [TBL] [Abstract][Full Text] [Related]
15. Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice. Han G; Gu B; Cao L; Gao X; Wang Q; Seow Y; Zhang N; Wood MJ; Yin H Nat Commun; 2016 Mar; 7():10981. PubMed ID: 26964641 [TBL] [Abstract][Full Text] [Related]
16. In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Aoki Y; Nakamura A; Yokota T; Saito T; Okazawa H; Nagata T; Takeda S Mol Ther; 2010 Nov; 18(11):1995-2005. PubMed ID: 20823833 [TBL] [Abstract][Full Text] [Related]
17. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy. Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246 [TBL] [Abstract][Full Text] [Related]
18. Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice. Yang L; Niu H; Gao X; Wang Q; Han G; Cao L; Cai C; Weiler J; Yin H PLoS One; 2013; 8(4):e61584. PubMed ID: 23658612 [TBL] [Abstract][Full Text] [Related]